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Introduction 
Cutaneous manifestations can often herald 
immunodeficiency disorders. Primary immune-
deficiency disorders (PIDs) are rare, chronic disorders 
found predominantly in children. They are 
characterized by inherited defects of the innate and 
adaptive immune systems. After the hematopoietic 
system, the skin is the second most commonly 
affected organ in PIDs, with involvement in 40-70% 
of cases [1-3]. In this review, we present the clinical 
features, in particular cutaneous manifestations, of 
several PIDs. 
1.0 Disorders affecting cellular and humoral 
immunity 
1.1 Hyper-IgM syndrome 
Hyper-IgM syndromes result from defective 
immunoglobulin class switching [4]. The most 
common variant is an X-linked recessive disorder, 
first identified in two boys with recurrent bacterial 
pneumonia and other bacterial infections [5], both 
hallmarks of the disorder. It is characterized by low 
levels of circulating B lymphocytes [6] and results 
from a defect in the CD40 ligand expressed on T 
lymphocytes [6-8]. CD40 ligand complexes with the 
B-cell protein CD40 to drive B-cell proliferation and 
differentiation and immunoglobulin class switching 
[6, 8]. Consequently, patients exhibit normal to 
elevated serum levels of IgM, with risk of IgM 
secreting lymphomas later in life, and decreased 
levels of IgG, IgA, and IgE [4, 6]. 
Affected boys typically present with a 
sinopulmonary infection, but also commonly 
experience neutropenia and increased sensitivity to 
Abstract 
Immunodeficiency is most commonly related to 
inherited syndromes, infections, chemotherapy, or 
aging. As the population of individuals with 
immunodeficiency continues to grow, physicians are 
confronted with the task of diagnosing dermatologic 
disease in this population. Cutaneous involvement in 
immunodeficiency disorders serves as a useful tool 
that aids diagnosis and provides prognostic value. 
Given that cutaneous manifestations often herald an 
underlying immunodeficiency disorder, 
understanding the complexities of these diseases is 
important for appropriate clinical management. 
Although certain diseases may present with 
stereotypical cutaneous lesions, others may involve 
more variable lesions that require specialized 
consultation for diagnosis and treatment 
recommendations. In this review, we discuss a 
number of cutaneous findings associated with 
primary immunodeficiencies. Awareness of these 
cutaneous associations may aid in the early detection 
and prompt treatment of these potentially serious 
immunologic disorders. 
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Pneumocytis jirovecii pneumonia, Cryptosporidium 
liver disease, and inflammatory liver and/or 
gastrointestinal diseases [4]. Cutaneous 
manifestations of hyper-IgM syndrome most 
frequently include warts and oral ulcers of the 
tongue and buccal mucosa, which are present in 
87.5% of neutropenic patients [9]. In addition, widely 
disseminated cutaneous warts and cutaneous 
sarcoid-like granulomas and histoplasmosis, 
although rare, have been reported [4, 10, 11]. 
1.1.2 Severe combined immunodeficiency (SCID) 
SCID is a combined B‐ and T‐cell immunodeficiency 
disorder that can result from numerous genetic 
mutations. As such, it exhibits various inheritance 
patterns and has the potential to produce 
heterogeneous clinical presentations [12, 13]. 
Occurring in 45% of cases [14], the most common 
cause of SCID is a non-functional gamma chain, a 
component of the interleukins and interleukin 
receptors inherent to proper B- and T-cell 
development and differentiation [12]. The disease is 
characterized by a marked depression in T-cell levels, 
with a normal or elevated number of B cells [12]. 
However, these B cells exhibit poor function owing 
to abnormal cell surface receptors [12] that 
accordingly results in decreased levels of 
immunoglobulin [12]. In essense, these children lack 
an immune system and are thus highly susceptible to 
infection. 
Signs of SCID, including various microbial infections 
and failure to thrive, present around six months of 
age [15]. Cutaneous manifestations include 
persistent mucocutaneous candidiasis of the mouth 
and anus, monilial diaper dermatitis, and 
gangrenous vaccinia cutaneous infections [15]. 
Moreover, otherwise benign infections, such as 
varicella zoster, can be refractory to treatment or 
even life threatening. Omenn syndrome, an 
autosomal recessive variant of SCID, typically 
presents with exfoliative erythroderma in the early 
neonatal period [16]. 
1.2 Combined immunodeficiencies with associated or 
syndromic features 
1.2.1 Wiskott-Aldrich syndrome 
Wiskott-Aldrich syndrome is an X-linked recessive 
disorder that manifests after the first month of life. 
The clinical phenotype consists of a triad of 
thrombocytopenia with small platelet size, atopic 
dermatitis, and recurrent bacterial infections, though 
many patients do not exhibit all three features [14]. 
Thrombocytopenia can produce skin findings such 
as bleeding from mucosal sites and 
thrombocytopenic purpura [15-17]. Atopic 
dermatitis occurs in over 80% of patients [14]. 
Patients have low levels of IgM, normal levels of IgG, 
and elevated levels of IgA and IgE. Delayed-type 
hypersensitivity is defective, with anergy to common 
antigens [18]. The average individual lives about four 
year  and the select few patients who survive into 
adolescence often develop lymphomas [19]. 
1.2.2 Ataxia-telangiectasia  
Ataxia-telangiectasia is an autosomal recessive 
disorder of abnormal DNA repair resulting in 
profound immunologic disturbances [20]. Unlike 
typical cells that cease DNA synthesis in response to 
double stranded breaks caused by radiation and 
radiation mimetic agents such as bleomycin, cells 
affected by ataxia-telangiectasia lack this protective 
mechanism and divide before errors are corrected 
[21, 22]. Additionally, T cells are often deficient. 
Autoimmune abnormalities are common and the risk 
of lymphoma is significantly elevated [20]. 
The most common clinical features of ataxia-
telangiectasia are bulbar telangiectasias and ataxia 
resulting from progressive degeneration of the 
Purkinje cells of the cerebellum [20]. Bulbar 
telangiectasias typically appear at two years’ of age, 
in sun-exposed areas [20]. Other common cutaneous 
features include café au lait macules, impetigo, AD, 
seborrheic dermatitis (SD), vitiligo, loss of 
subcutaneous fat, and premature poliosis [21, 23]. 
Most patients develop recurrent sinopulmonary 
infections, with pneumonia as the most common 
cause of death [21, 23]. 
1.2.3 Bloom syndrome 
Bloom syndrome is a rare autosomal recessive 
disorder that occurs primarily in Ashkenazi Jews [21, 
24]. The condition is caused by a mutation in the BLM 
gene located on chromosome 15. This gene encodes 
RecQ helicase, which is critical for maintaining DNA 
stability during replication and repair. Without this 
protein, cells in these patients commonly display 
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high rates of baseline sister chromatid exchanges 
and chromosomal aberrations known as 
quadriradical figures [24]. Neonates with Bloom 
syndrome demonstrate low birth weight and 
elongation of the head [25]. Telangiectasias appear 
in sun-exposed areas, predominantly on the nose, 
malar area, and dorsum of the hands. 
Photosensitivity may lead to scarring and atrophy 
[21]. Café au lait macules are commonly seen. 
Patients also remain susceptible to infections and 
show low levels of immunoglobulins [25]. Avoiding 
exposure to ultraviolet light and consistent use of 
sunscreens can mitigate the cutaneous changes [25]. 
Patients are also predisposed to neoplasia, especially 
acute leukemia, lymphoma, and squamous cell 
carcinoma of the tongue, often leading to premature 
death [21, 26]. 
1.2.4 Hyper-IgE syndrome (Job syndrome) 
Hyper-IgE syndrome was discovered in two girls with 
severe dermatitis, recurrent staphylococcal 
infections with “cold” abscess formation, and an 
abnormal inflammatory response [27, 28]. Disease 
pathogenesis is attributed to sporadic or inherited 
autosomal dominant defects in the Janus activated 
kinase-signal transducer and activator of 
transcription (JAK-STAT) pathway, which regulates 
IL2 and IL6 cytokine signaling [29]. Notably, 
abnormalities in this pathway lead to defective 
differentiation of the Th17 cell type, although the 
specific mechanisms underlying disease 
pathogenesis are not well-defined. 
The most common presenting manifestation of this 
autosomal dominant disorder is a papulopustular 
eruption in the first month of life primarily affecting 
the face and scalp [28, 30]. Later skin findings include 
retroauricular fissures, otitis externa, dermatitis of 
the axillae and groin, folliculitis of the upper back 
and shoulders, and pitted scarring of the face [28]. 
Patients are susceptible to superficial and systemic 
bacterial and fungal infections [28]. Specifically, 
Staphylococcus aureus often causes abscesses of the 
skin and lungs, Candida albicans leads to 
mucocutaneous candidiasis, and Aspergillus species 
commonly contribute to lung disease [31, 32]. Lastly, 
most patients develop a dermatitis that resembles 
atopic dermatitis [33]. 
1.3. Disorders with predominantly immunoglobulin 
deficiencies 
1.3.1 X-linked agammaglobulinemia, (Bruton hypo-
gammaglobulinemia) 
X-linked agammaglobulinemia was first described in 
boys with recurrent bacterial infections during the 
first year of life [18]. One boy developed caseating 
granulomas containing CD8+ cells with no infectious 
isolates [34]. X-linked agammaglobulinemia is 
caused by mutation of BTK receptors, which results 
in abnormal B-cell differentiation and defective 
antibody signaling [35]. The disease is characterized 
by complete absence of circulating B cells and 
plasma cells, with decreased (IgG) or absent (IgA and 
IgM) levels of immunoglobulins [38-40]. Despite 
absent B cells, B cell precursors are abundant, 
suggesting defective B-cell differentiation [38]. 
Maternal transfer of immunoglobulins delays 
infection; however, severe and repeated bacterial 
infections of the skin, respiratory tract, and meninges 
occurring by the second year of life [38]. In particular, 
staphylococcal infections such as furunculosis are 
common [15, 36, 37]. Patients may demonstrate a 
normal immune response to some viruses, fungi, and 
gram-negative bacteria given intact T cell response 
[37]. 
1.3.2 Common variable immunodeficiency  
Common variable immunodeficiency is the most 
common primary immunodeficiency [38]. Molecular 
pathogenesis of this disorder has not been fully 
uncovered; however, genetic susceptibility is seen in 
20% of patients with dominant inheritance [39]. 
Diagnosis is based on reduced levels of IgG in 
addition to IgA, IgM, or both [39]. Approximately 
one-third of patients also demonstrate functional 
impairment of T cells [39]. 
The majority of patients present with recurrent 
sinopulmonary infections. Other features include 
gastrointestinal disturbances, granulomatous 
inflammation, and unusual infectious presentations 
related to enterovirus and Mycoplasma species [39]. 
Cutaneous granulomas of the leg and cutaneous 
viral infections are common, including recurrent 
cutaneous enterovirus infection causing hand, foot, 
and mouth disease, recurrent attacks of herpes 
simplex virus infection, herpes zoster, and 
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epidermodysplasia verruciformis [40-42]. Other 
cutaneous manifestations include elastosis 
perforans serpiginosa, pyoderma gangrenosum, 
polymorphic light eruption, and alopecia areata [43-
45]. 
1.4 Disorders affecting phagocyte function 
1.4.1 Chronic granulomatous disease  
Chronic granulomatous disease exists in both an 
autosomal recessive and X-linked form, with the 
latter occurring in more than 50% of patients [46]. 
Chronic granulomatous disease is caused by gene 
mutations encoding essential subunits of the NADPH 
oxidase complex, the enzyme required for synthesis 
of reactive oxygen intermediates during the 
respiratory burst [46, 47]. Without NADPH oxidase 
and resultant superoxide radicals, neutrophils fail to 
increase oxygen consumption for the destruction of 
phagocytosed bacteria and fungi [48, 49]. As a result, 
patients with chronic granulomatous disease 
develop recurrent bacterial and fungal infections 
complicated by granuloma formation [46]. The most 
common organisms associated with infection in 
chronic granulomatous disease are S. aureus, 
Escherichia coli, and species of Klebsiella, 
Pseudomonas, Aspergillus, and Candida [50]. 
Cutaneous manifestations occur in at least of 60-70% 
patients with chronic granulomatous disease [51]. 
One of the earliest features of the disease is a 
dermatitis, which represents an infectious 
periorificial process rather than classic atopic 
dermatitis [51]. Another cutaneous finding is 
draining, suppurative lymph nodes resembling 
scrofula in the neck and inguinal regions [51]. 
Bacterial skin infections, including chronic 
suppurative paronychia, impetigo around the nares 
and ears, facial pustules, furunculosis, and 
subcutaneous abscesses, are a recurrent feature of 
untreated chronic granulomatous disease [51]. Other 
less common cutaneous manifestation include 
vesicular skin lesions and cutaneous granulomas 
[54]. 
1.4.2 Chediak-Higashi syndrome 
Chediak-Higashi syndrome is an autosomal recessive 
disorder characterized by impaired phagocytosis 
related to defects in vesicle trafficking [52, 53]. The 
genetic basis for Chediak-Higashi syndrome is 
generally attributed to mutations in the CHS1/LYST 
genes, although much genetic heterogeneity exists. 
Chediak-Higashi syndrome exhibits features such as 
partial oculocutaneous albinism and recurrent 
infections primarily with S. aureus, β-hemolytic 
streptococcus, and various fungi [52, 53]. Chediak-
Higashi syndrome involves defects in cytoplasmic 
organelles such as melanosomes, lysosomes, and 
cytoplasmic secretory granules. As a result, 
melanocytes contain giant melanosomes and 
myeloid and lymphoid cells exhibit defective 
phagocytosis [52-54]. Neutrophils in Chediak-
Higashi syndrome exhibit impaired chemotaxis 
causing poor intracellular destruction of pathogens 
and natural-killer cells have poor function because of 
defective secretory granules [52]. Cutaneous 
findings include skin with a slate-gray hue and blue 
to brown-colored irises [55]. Hair is usually blonde 
but may have a metallic sheen because of clumping 
of melanin in the hair shaft [55]. 
Griscelli syndrome and Hermansky-Pudlak syndrome 
are disorders related to Chediak-Higashi syndrome 
but are significantly less common [56]. Like Chediak-
Higashi syndrome, Griscelli syndrome is caused by 
defects in vesicle trafficking, whereas Hermansky-
Pudlak syndrome involves defects in vesicle 
formation [57]. 
1.4.3 Myeloperoxidase deficiency 
Myeloperoxidase deficiency is an autosomal 
recessive disorder characterized by the absence or 
inactivity of the enzyme myeloperoxidase [58, 59]. 
Myeloperoxidase catalyzes several oxidative 
reactions necessary for the proper functioning of 
polymorphonuclear cells, notably production of the 
microbicidal agent hypochlorous acid and 
termination of the respiratory burst [58, 59]. Most 
patients with myeloperoxidase deficiency are 
relatively asymptomatic, although they exhibit 
increased susceptibility to systemic candidiasis in the 
presence of diabetes mellitus [59, 60]. Cutaneous 
findings include recurrent acne, skin infections, and 
Sweet syndrome [61, 62]. 
1.4.4 Leukocyte adhesion deficiency 
Leukocyte adhesion deficiency is an autosomal 
recessive disorder involving an absence of the β2-
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integrin subunit (CD18), which prevents neutrophils 
aggregation [63]. Because neutrophils cannot exit 
the peripheral circulation and enter infected tissue, 
the peripheral blood shows a persistent leukocytosis 
[64]. Recurrent cutaneous infections are common 
and are generally secondary to S. aureus or gram‐
negative bacilli such as Pseudomonas aeruginosa or 
species of Enterobacter, Klebsiella, Proteus, and 
Serratia [65]. Because impaired neutrophil function 
precludes the formation of overt pustules or 
abscesses, microbial inflammation results in 
ulcerations similar to pyoderma gangrenosum [63]. 
Other clinical features include delayed umbilical cord 
separation and omphalitis [64]. 
1.5 Other disorders 
Dyskeratosis congenita is a genetically 
heterogeneous condition characterized by short 
telomeres. The disease is classically known for the 
triad of oral leukoplakia, nail dystrophy, and reticular 
skin pigmentation, but affected individuals are also 
at high risk for bone marrow failure, pulmonary 
fibrosis, and cancer [66]. Comèl‐Netherton syndrome 
is an autosomal recessive disorder with reduced 
memory B cells and deficient NK cytotoxicity that 
presents in infancy [67]. It is characterized by 
congenital ichtyosis, atopic diseases, and 
trichorrhexis invaginate, or “bamboo hairs.” Cases of 
exfoliative erythroderma and hypernatremia have 
also been reported. Papillon-Lefèvre syndrome is an 
autosomal recessive disorder of impaired 
chemotaxis featuring ectodermal dysplasia and 
palmoplantar hyperkeratosis [68]. Autoimmune 
polyendocrinopathy-candidiasis-ectodermal 
dystrophy is an autosomal recessive disorder of 
impaired immune tolerance, resulting in cutaneous 
autoimmune diseases such as vitiligo and alopecia 
areata [69]. Cartilage‐hair hypoplasia is an autosomal 
recessive form of short-limbed dwarfism that 
involves cell-mediated immunodeficiency and the 
appearance of hypoplastic, light-colored hair [70]. 
Lastly, selective IgA deficiency is an inherited 
condition that can be associated with a dermatitis 
similar to atopic dermatitis [71]. 
 
Conclusion 
Cutaneous lesions are common manifestations of 
immunodeficiency. An immunologic workup may be 
necessary to evaluate for a possible primary 
immunodeficiency disorder if a pediatric patient 
presents with failure to thrive, multisystem 
involvement, and recurrent infections. Although 
these disorders are rare, recognition of characteristic 
dermatologic manifestations can facilitate earlier 
diagnosis and identify appropriate therapies for 
patients. 
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